Finally, experimental data showed overexpression of sodium-glucose cotransporter 2 (SGLT2) in colon cancer cells, and one study suggested beneficial effects of SGLT2 inhibitors in an animal model of CRC [200]. The gene discussed is SLC5A2; the disease is colonic neoplasm.